12.3.2025 08:49:28 CET | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state
Reference is made to the announcement by Aqua Bio Technology ASA on 11 March
2025 concerning the successful placement of the conditional private placement
with total gross proceeds of approximately NOK 24.2 million, and a contemplated
subsequent offering (the "Subsequent Offering"), and to the announcement with
key information for the Subsequent Offering.
The shares in Aqua Bio Technology ASA will be traded exclusive of the right to
receive subscription rights in the Subsequent Offering as of today, 12 March
2025.
This information is published in accordance with the requirements of the
Continuing Obligations in Euronext Rule Book II.
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
CONTACTS
* Fredrik Henriksen, CEO, Aqua Bio Technology ASA, +47 90 02 00 78,
fredrik.henriksen@aquabiotech.no
ABOUT AQUA BIO TECHNOLOGY ASA
Aqua Bio Technology ASA (ABT) is a distribution group in skincare and nonfood.
The group has distribution towards B2C, B2B, B2B2, and freight, customs, and
logistics services. The group also develops sustainable biotechnology for use in
skincare products. Aqua Bio Technology is listed on the Euronext Expand market
of the Oslo Stock Exchange.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18452650/5769/Download%20announce
ment%20as%20PDF.pdf